Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3891496017 | Conjugated estrogen 625 microgram oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3891497014 | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46706901000001119 | Conjugated oestrogens 625microgram tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing conjugated estrogen | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Conjugated estrogen | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Conjugated estrogen | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Conjugated estrogen | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.625 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Conjugated estrogen | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing conjugated estrogen in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 625 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only conjugated estrogen in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Conjugated oestrogens | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Conjugated estrogen | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has specific active ingredient | Conjugated estrogen | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Conjugated oestrogens 625micrograms tablet - product | Is a | False | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Premarin 625microgram tablets (Wyeth Laboratories) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets (Wyeth Laboratories) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Premarin 625microgram tablets (PI) (Waymade Ltd) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets (PI) (Waymade Ltd) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Premarin 625microgram tablets (PI) (Dowelhurst Ltd) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets 42 tablet | Is pack of | False | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets 84 tablet | Is pack of | False | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Premarin 0.625mg tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets 84 tablet | Has VMP | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Conjugated oestrogens 625microgram tablets 42 tablet | Has VMP | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Premarin 0.625mg tablets (Necessity Supplies Ltd) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Premarin 0.625mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely conjugated estrogen 625 microgram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR